Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180730040640N1Phase 3Completed
Phase 3, randomised, double-blind trial in chronic rhinosinusitis (CRS) comparing Tranexamic acid + phenylephrine with Phenylephrine control (2 arms). Primary endpoints: Bleeding during surgery and Quality of surgical field. Started Sep 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180730040640N1.